• 52,780+ CME Conference Registrations Sold
  • 158,339+ Medical Conferences
  • 285 Specialties
  • 11,430 Organizers
  • 157,205 Speakers
  • 159 Countries
  • 4,804 Cities

Neurology : Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome is organized by American Academy of Neurology (AAN) and will be held during Aug 29, 2017 - Aug 29, 2020.

Conference Objectives are :

Upon completion of the article by Hennes et al, the participant should be able to:
• Identify clinical features in this study seen in conjunction with high anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a cohort of children with acquired demyelinating syndromes
• Describe the prognostic role for anti-MOG antibodies in identifying children after an initial demyelinating event who are at high risk of subsequent development of multiple sclerosis (MS) in this study
• Discuss the sensitivity and specificity of anti-MOG antibodies in the diagnosis of non-MS disease courses following an initial demyelinating event observed in this study

Additional details will be posted as soon as they are available.

Intended Audience


Activity Payment Details

Activity Fee : NA

Rate this CME (Min 1 - Max 5)

Fee and expenses:
CME credits:
Program contents:
Write Your Review

Reviews Given by Professionals

No Reviews available. Be the first to write a review.

Privacy Policy

Read eMedEvents Privacy Policy


American Academy of Neurology (AAN)

View Organizer Details


(800) 879-1960, (612) 928-6000

Live to Virtual Conference

Market your online event to Million plus Healthcare professionals.